Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 10, Issue 5, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-05-01
DOI
10.1038/s41419-019-1593-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- T cell acute lymphoblastic leukemia (T-ALL): New insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignancies
- (2018) Eduardo Vadillo et al. BLOOD REVIEWS
- CCL2/CCL5 secreted by the stroma induce IL-6/PYK2 dependent chemoresistance in ovarian cancer
- (2018) Jennifer Pasquier et al. Molecular Cancer
- Alpha2beta1 Integrin (VLA-2) Protects Activated Human Effector T Cells From Methotrexate-Induced Apoptosis
- (2018) Amna Abderrazak et al. Frontiers in Immunology
- Signal transduction via integrin adhesion complexes
- (2018) Jonathan D Humphries et al. CURRENT OPINION IN CELL BIOLOGY
- Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting
- (2016) Francesca Chiarini et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- T-cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments
- (2016) Edwin D. Hawkins et al. NATURE
- The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2/β-catenin signaling in human multiple myeloma
- (2016) Yusuke Kamihara et al. Oncotarget
- CXCR4 Is Required for Leukemia-Initiating Cell Activity in T Cell Acute Lymphoblastic Leukemia
- (2015) Diana Passaro et al. CANCER CELL
- CXCL12-Producing Vascular Endothelial Niches Control Acute T Cell Leukemia Maintenance
- (2015) Lauren A. Pitt et al. CANCER CELL
- Normal and Leukemic Stem Cell Niches: Insights and Therapeutic Opportunities
- (2015) Koen Schepers et al. Cell Stem Cell
- Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies
- (2015) Zhaoyang Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting of β1 integrins impairs DNA repair for radiosensitization of head and neck cancer cells
- (2015) E Dickreuter et al. ONCOGENE
- Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma
- (2015) M B Meads et al. ONCOGENE
- Focal adhesion signaling and therapy resistance in cancer
- (2015) Iris Eke et al. SEMINARS IN CANCER BIOLOGY
- Pyk2 promotes tumor progression in multiple myeloma
- (2014) Y. Zhang et al. BLOOD
- Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF- B mediates chemoresistance
- (2014) R. Jacamo et al. BLOOD
- Alpha2beta1 integrin promotes T cell survival and migration through the concomitant activation of ERK/Mcl-1 and p38 MAPK pathways
- (2014) Dalila Naci et al. CELLULAR SIGNALLING
- Functions of the FAK family kinases in T cells: beyond actin cytoskeletal rearrangement
- (2014) Nicole M. Chapman et al. IMMUNOLOGIC RESEARCH
- CD49d Is the Strongest Flow Cytometry–Based Predictor of Overall Survival in Chronic Lymphocytic Leukemia
- (2014) Pietro Bulian et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy
- (2013) Y.-T. Hsieh et al. BLOOD
- Cooperativity of CD44 and CD49d in Leukemia Cell Homing, Migration, and Survival Offers a Means for Therapeutic Attack
- (2013) V. Singh et al. JOURNAL OF IMMUNOLOGY
- SP/drug efflux functionality of hematopoietic progenitors is controlled by mesenchymal niche through VLA-4/CD44 axis
- (2013) J-V Malfuson et al. LEUKEMIA
- The Membrane-Proximal KXGFFKR Motif of -Integrin Mediates Chemoresistance
- (2013) C.-C. Liu et al. MOLECULAR AND CELLULAR BIOLOGY
- Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?
- (2012) C.-H. Pui et al. BLOOD
- α2β1 Integrin Promotes Chemoresistance against Doxorubicin in Cancer Cells through Extracellular Signal-regulated Kinase (ERK)
- (2012) Dalila Naci et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Acquisition of Resistance toward HYD1 Correlates with a Reduction in Cleaved 4 Integrin Expression and a Compromised CAM-DR Phenotype
- (2011) M. F. Emmons et al. MOLECULAR CANCER THERAPEUTICS
- Gene-based outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group study
- (2010) Amanda L Cleaver et al. Molecular Cancer
- Multidrug Resistance-Related Protein 1 (MRP1) Function and Localization Depend on Cortical Actin
- (2010) I. Hummel et al. MOLECULAR PHARMACOLOGY
- Single-Cell STAT5 Signal Transduction Profiling in Normal and Leukemic Stem and Progenitor Cell Populations Reveals Highly Distinct Cytokine Responses
- (2009) Lina Han et al. PLoS One
- 1 Integrin Inhibition Dramatically Enhances Radiotherapy Efficacy in Human Breast Cancer Xenografts
- (2008) C. C. Park et al. CANCER RESEARCH
- The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance
- (2008) M. B. Meads et al. CLINICAL CANCER RESEARCH
- Bortezomib overcomes cell adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma
- (2008) K Hatano et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search